PSC
COLL icon

Piper Sandler & Co’s Collegium Pharmaceutical COLL Stock Holding History

Piper Sandler & Co’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-599
Closed -$16K – 21
2015
Q4 		$16K Sell
599
-201
-25% -$4.24K 0.04% 25
2015
Q3 		$18K Sell
800
-4,796
-86% -$86.7K 0.02% 99
2015
Q2 		$100K Buy
+5,596
New +$96.8K 0.06% 93

Other funds holding COLL

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Piper Sandler & Co's COLL Position: Q1 2016 in Review

Piper Sandler & Co sold out of Collegium Pharmaceutical (COLL) in Q1 2016, closing a stake of 599 shares — an estimated $16K sold.

Piper Sandler & Co first reported a position in COLL in Q2 2015 and held it in 3 quarters. The position peaked at $100K in Q2 2015. 70 funds tracked by Wall St. Rank hold COLL as of Q1 2016.

  • Piper Sandler & Co reported no remaining Collegium Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Piper Sandler & Co sold 599 Collegium Pharmaceutical shares in Q1 2016, an estimated $16K.
  • Piper Sandler & Co first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 3 quarters.
  • Piper Sandler & Co's Collegium Pharmaceutical position peaked at $100K in Q2 2015.
  • 70 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2016.

Based on Piper Sandler & Co's 13F filing for Q1 2016, filed 16 May 2016.